{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:58:08Z","timestamp":1777532288474,"version":"3.51.4"},"reference-count":67,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Med Insights Circ Respir Pulm Med"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>In the last years, the presence of multidrug-resistant (MDR) Gram-negative (like Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii) and Gram-positive bacteria (mostly methicillin-resistant Staphylococcus aureus) was worldwide reported, limiting the options for an effective antibiotic therapy. For these reasons, inappropriate antimicrobial therapy and delayed prescription can lead to an unfavorable outcome, especially in patients with pneumonia. New antibiotics approved belong to classes of antimicrobials, like beta-lactams with or without beta-lactamase inhibitors, aminoglycosides, oxazolidinones, quinolones, and tetracyclines, or based on new mechanisms of action. These new compounds show many advantages, including a broad spectrum of activity against MDR pathogens, good lung penetration, safety and tolerability, and finally the possibility of intravenous and\/or oral formulations. However, the new antibiotics under development represent an important possible armamentarium against difficult-to-treat strains. The safety and clinical efficacy of these future drugs should be tested in clinical practice. In this review, there are reported characteristics of newly approved antibiotics that represent potential future options for the treatment of respiratory tract infections, including those caused by multidrug-resistant bacteria. Finally, the characteristics of the drugs under development are briefly reported.<\/jats:p>","DOI":"10.1177\/1179548420982786","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:40:46Z","timestamp":1608511246000},"page":"117954842098278","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Spotlight on New Antibiotics for the Treatment of Pneumonia"],"prefix":"10.1177","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3846-4620","authenticated-orcid":false,"given":"Alessandro","family":"Russo","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,12,20]]},"reference":[{"key":"bibr1-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02582-14"},{"key":"bibr2-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-016-2694-9"},{"key":"bibr3-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-017-0179-5"},{"key":"bibr4-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3719-z"},{"key":"bibr5-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1119-1"},{"key":"bibr6-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181a037ac"},{"key":"bibr7-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/38.5.865"},{"key":"bibr8-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099044"},{"key":"bibr9-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir895"},{"key":"bibr10-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12463"},{"key":"bibr11-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4682-7"},{"key":"bibr12-1179548420982786","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13054-016-1197-5","volume":"29","author":"Bassetti M","year":"2016","journal-title":"Crit Care"},{"key":"bibr14-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.3.825-836.2001"},{"key":"bibr15-1179548420982786","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200847010-00003"},{"key":"bibr16-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu219"},{"key":"bibr17-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.11.005"},{"key":"bibr18-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr096"},{"key":"bibr19-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr097"},{"key":"bibr20-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)71018-7"},{"key":"bibr21-1179548420982786","first-page":"204993611880865","volume":"6","author":"Rosanova MT","year":"2018","journal-title":"Ther Adv Infect Dis"},{"key":"bibr22-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.05.023"},{"key":"bibr23-1179548420982786","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060824"},{"key":"bibr24-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1378\/chest.1704989"},{"key":"bibr25-1179548420982786","unstructured":"Maggiore C, Pasquale T, Jandourek A, Smith A, Friedland HD. Experience with ceftaroline fosamil as monotherapy and combination therapy with vancomycin in acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. ASHP Midyear Meeting 2013. Orlando, FL: American Society of Health-System Pharmacists; 2013:5-112."},{"key":"bibr26-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105921"},{"key":"bibr27-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02429-13"},{"key":"bibr28-1179548420982786","volume":"58","author":"Keepers TR","year":"2014","journal-title":"Pseudomonas aeruginosa. Antimicrob Agents Chemother"},{"key":"bibr29-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30747-8"},{"key":"bibr30-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix783"},{"key":"bibr31-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00883-17"},{"key":"bibr32-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000438"},{"key":"bibr33-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.748653"},{"key":"bibr34-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks523"},{"key":"bibr35-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.07.004"},{"key":"bibr36-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01964-15"},{"key":"bibr37-1179548420982786","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2017-0018"},{"key":"bibr38-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix014"},{"key":"bibr39-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01566-16"},{"key":"bibr40-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.566"},{"key":"bibr41-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix182"},{"key":"bibr42-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ097"},{"key":"bibr43-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00567-17"},{"key":"bibr44-1179548420982786","first-page":"62","author":"Hackel MA","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"bibr45-1179548420982786","first-page":"61","author":"Sun D","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"bibr46-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00568-16"},{"key":"bibr47-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01536-15"},{"key":"bibr48-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01242-13"},{"key":"bibr49-1179548420982786","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1128\/AAC.01393-16","volume":"60","author":"Sun H","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"bibr50-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00197-13"},{"key":"bibr51-1179548420982786","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1473-3099(16)00017-7","volume":"16","author":"Barrera CM","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"bibr52-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw490"},{"key":"bibr53-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00773-15"},{"key":"bibr54-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq335"},{"key":"bibr55-1179548420982786","first-page":"859","volume-title":"Drugs","volume":"70","author":"Zhanel GG","year":"2010"},{"key":"bibr56-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01110-07"},{"key":"bibr57-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq031"},{"key":"bibr58-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041870"},{"key":"bibr59-1179548420982786","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.14.4"},{"key":"bibr60-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt490"},{"key":"bibr61-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.12.006"},{"key":"bibr62-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz090"},{"key":"bibr63-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz086"},{"key":"bibr64-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz088"},{"key":"bibr65-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02161-18"},{"key":"bibr66-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2166"},{"key":"bibr67-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2019.1677607"},{"key":"bibr68-1179548420982786","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2018.08.007"}],"container-title":["Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1179548420982786","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1179548420982786","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1179548420982786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:47:59Z","timestamp":1777394879000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1177\/1179548420982786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":67,"alternative-id":["10.1177\/1179548420982786"],"URL":"https:\/\/doi.org\/10.1177\/1179548420982786","relation":{},"ISSN":["1179-5484","1179-5484"],"issn-type":[{"value":"1179-5484","type":"print"},{"value":"1179-5484","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}